Lv63
1680 积分 2026-01-12 加入
Discovery of a Potent APOBEC3B Inhibitor to Augment Antitumor Immunity and Reduce Inflammatory Toxicity
14小时前
待确认
Interstitial lung disease in patients treated with antibody–drug conjugates: a review
16小时前
待确认
A modular framework for antibody–drug conjugate biomarkers
25天前
已完结
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
1个月前
已完结
Dual Targeting of EGFR and HER2 by a Bispecific Antibody-Drug Conjugate Demonstrates Broad Antitumor Activity in Multiple Solid Tumors
2个月前
已完结
Multispecific T-cell engagers attract cancer drug developers
3个月前
已完结
Advanced cardiac organoid model for studying doxorubicin-induced cardiotoxicity
3个月前
已完结
From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation
3个月前
已完结
FDA pushes to replace animal testing
3个月前
已完结
Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets
3个月前
已完结
皖公网安备34019202002308
